| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |